StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3046% above fair value
$646.87−6.22 (-0.95%)

Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –

Medpace price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Medpace's price to sales ratio was 6.7× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 3.6× to 7.4×, with a median of 5.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.7×−0.0
2025Dec 31, 20256.7×+1.7
2024Dec 31, 20245.0×−0.3
2023Dec 29, 20235.3×+0.5
2022Dec 30, 20224.8×−2.3
2021Dec 31, 20217.2×+1.6
2020Dec 31, 20205.6×+1.9
2019Dec 31, 20193.7×+0.7
2018Dec 31, 20183.0×−0.2
2017Dec 29, 20173.2×−0.8
2016Dec 30, 20164.1×–

More Medpace figures

See a number that looks wrong?